The FDA approved a new 300 mg/2 mL dose of Celltrion’s omalizumab biosimilar, Omlyclo, for the treatment of four allergic and ...

Alcami's new sterile fill-finish line supports vial formats from 2R to 30R, enhancing clinical and commercial manufacturing ...

The FDA approved Lerochol, a monthly PCSK9 inhibitor, for adults with hypercholesterolemia to reduce LDL-C levels alongside diet and exercise.

A third-generation PCSK9 inhibitor, lerodalcibep is indicated as an adjunct to diet and exercise to reduce LDL cholesterol in ...

Methotrexate is widely prescribed for arthritis, psoriasis, and certain cancers. Here’s what patients need to know about ...

People taking methotrexate for a variety of conditions have been warned by the NHS that a number of symptoms and side effects ...

(RTTNews) - Celltrion Inc. announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of OMLYCLO (omalizumab-igec)—the first and only biosimilar designated as ...

At least a handful of Thanksgiving shoppers were disheartened when they went to prepare the holiday staple cranberry sauce last week and found their cans of Ocean Spray did not contain the sauce but ...

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive ...

Fresenius Kabi, a provider of essential medicines and medical technologies, has introduced two new products in its Simplist portfolio of ready-to-administer prefilled syringes: Simplist Ephedrine ...